Dianthus Therapeutics Inc (DNTH) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Dianthus Therapeutics Inc   (NASDAQ: DNTH)


Dianthus Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Dianthus Therapeutics Inc 's ROA in the second quarter of 2026?
Dianthus Therapeutics Inc recorded a cumulative net loss of $-192 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -21.6%.

However, within the Healthcare sector 434 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 3790 to 4388.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 334.43 % 339.76 % 45.45 % 75.81 % -23.67 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -192 -174 -162 -126 -115
Return On Assets (TTM) -21.6 % -26.45 % -39.06 % -33.77 % -36.68 %
DNTH's Total Ranking # 4388 # 3790 # 3831 # 3802 # 4285
Total Assets (TTM) in million 1,213 1,247 531 569 279
Seq. Total Assets Change -2.7 % 134.85 % -6.67 % 103.7 % -1.5 %
Seq. Net Income Change - - - - -

DNTH's 5 Years Annual ROA >> Back to DNTH Management Effectiveness >> Compare DNTH ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 166
Sector # 435
Overall # 4059

Return On Assets Statistics
High Average Low
-15.12 %
-34.87 %
-49.45 %
(Jun 30 2024)   (Jun 30 2020)





Financial Statements
Dianthus Therapeutics Inc 's Assets $ 1,213 million DNTH's Balance sheet
Dianthus Therapeutics Inc 's Income $ -50 million Quarterly DNTH's Income Statement
DNTH's Income by Division See DNTH's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 72.21 % 103.91 % 22.34 % -22.79 % 17.52 %
Total Assets in million 630 366 179 147 190
Y / Y Net Income Change - - - - -
Net Income in million -162 -85 -44 -76 -71
Annual Return On Assets -25.77 % -23.23 % -24.28 % -52.14 % -37.45 %

DNTH's 5 Years Annual ROA >> Back to DNTH Management Effectiveness >> Compare DNTH ROA to its Competitors



More Return On Assets Ratios
DNTH's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DNTH's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DNTH's Competitors
Subscribers only: Roa for Dianthus Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for DNTH's Customers

You may also want to know
DNTH's Roi DNTH's Inventory Turnover Ratio DNTH's Growth Rates DNTH's Dividend Comparisons
DNTH's Profitability Ratios DNTH's Asset Turnover Ratio DNTH's Dividend Growth
DNTH's Roe DNTH's Valuation Ratios DNTH's Financial Strength Ratios DNTH's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-08-14T09:54:04+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.